David F Adams1, Teresa S Sellers1. Show Affiliations » 1. Clinical Pathology Department of Safety Assessment, GlaxoSmithKline, King of Prussia, Pennsylvania.
Abstract
Entities: Chemical
Mesh： See more » AdultAzo Compounds/chemistryBenzoates/adverse effectsBenzoates/bloodBenzoates/chemistryBenzoates/therapeutic useBilirubin/bloodColorColoring Agents/chemistryDiagnosis, DifferentialHematinics/adverse effectsHematinics/bloodHematinics/chemistryHematinics/therapeutic useHumansHydrazines/adverse effectsHydrazines/bloodHydrazines/chemistryHydrazines/therapeutic useHyperbilirubinemia/bloodHyperbilirubinemia/diagnosisHyperbilirubinemia/etiologyLeukemia, Myeloid, Acute/bloodLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/physiopathologyOsmolar ConcentrationPyrazoles/adverse effectsPyrazoles/bloodPyrazoles/chemistryPyrazoles/therapeutic useReceptors, Thrombopoietin/agonistsReceptors, Thrombopoietin/metabolismReproducibility of ResultsSerum/chemistrySpectrophotometryThrombocytopenia/diagnosisThrombocytopenia/etiologyThrombocytopenia/prevention & control
Substances： See more » Azo CompoundsBenzoatesColoring AgentsHematinicsHydrazinesPyrazolesReceptors, ThrombopoietinBilirubineltrombopag
Year: 2016 PMID： 27128294 DOI： 10.5858/arpa.2015-0473-LE
Source DB: PubMed Journal: Arch Pathol Lab Med ISSN： 0003-9985 Impact factor: 5.534